The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2+-Activated K+ Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing (2019)
Attributed to:
Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ph12030104
PubMed Identifier: 31277369
Publication URI: http://europepmc.org/abstract/MED/31277369
Type: Journal Article/Review
Parent Publication: Pharmaceuticals
Issue: 3
ISSN: 1424-8247